SMMT

Summit Therapeutics Inc.

A clinical-stage biopharmaceutical company founded in 2003 in Oxford, England, that develops new medicines for serious diseases — starting with antibiotics and later shifting its focus to cancer treatments such as the lung-cancer drug ivonescimab. It went through a string of odd early names, including CobraDragon and Vastox, before settling on "Summit," a nod to reaching the peak of healthcare. Today it is listed on Nasdaq and runs offices in Miami, California, and the UK.

Sponsored American Depositary Shares (ADS)

No Schedule 13D or 13G filings recorded.